These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22290317)

  • 1. [Neuroendocrine neoplasms of the gastrointestinal tract. Classification, clinical presentation and diagnosis].
    Fottner C; Weber MM
    Internist (Berl); 2012 Feb; 53(2):131-44. PubMed ID: 22290317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?
    Fottner C; Ferrata M; Weber MM
    Rev Endocr Metab Disord; 2017 Dec; 18(4):393-410. PubMed ID: 29256148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification.
    Anlauf M
    Horm Metab Res; 2011 Nov; 43(12):825-31. PubMed ID: 22105474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumors: An ENETS Center of Excellence Experience.
    Malczewska A; Witkowska M; Wójcik-Giertuga M; Kuśnierz K; Bocian A; Walter A; Rydel M; Robek A; Pierzchała S; Malczewska M; Leś-Zielińska I; Czyżewski D; Ziora D; Pilch-Kowalczyk J; Zajęcki W; Kos-Kudła B
    Neuroendocrinology; 2021; 111(4):304-319. PubMed ID: 32335553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors.
    Oberg K
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):109-12. PubMed ID: 22584714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances of circulating biomarkers in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L; Chen M; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):357-360. PubMed ID: 28338171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine neoplasms of the gastrointestinal tract.
    Schott M; Klöppel G; Raffel A; Saleh A; Knoefel WT; Scherbaum WA
    Dtsch Arztebl Int; 2011 May; 108(18):305-12. PubMed ID: 21629514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroendocrine tumors of the gastrointestinal tract].
    Arnold C
    Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition.
    Pobłocki J; Jasińska A; Syrenicz A; Andrysiak-Mamos E; Szczuko M
    Nutrients; 2020 May; 12(5):. PubMed ID: 32429294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Presentation and Diagnosis of Neuroendocrine Tumors.
    Vinik AI; Chaya C
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):21-48. PubMed ID: 26614367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.
    Alexandraki KI; Kaltsas G
    Endocrine; 2012 Feb; 41(1):40-52. PubMed ID: 22124940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interpretation of updated international guidelines for diagnosis and treatment of gastroenter-opancreatic neuroendocrine neoplasms].
    Chen LH; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):843-848. PubMed ID: 34674457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors.
    Singh S; Law C
    Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):313-34. PubMed ID: 22646254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostics and treatment of neuroendocrine tumors of the digestive tract in the light of the present standards].
    Szczeblowska D
    Pol Merkur Lekarski; 2007 May; 22(131):437-41. PubMed ID: 17679390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide suppression test in diagnosing and predicting the outcome of therapy in patients with neuroendocrine tumors. Preliminary report.
    Kos-Kudła B; Zemczak A; Foltyn W; Marek B; Strzelczyk J; Telega A; Zajecki W; Legaszewski T; Jurecka-Lubieniecka B
    Endokrynol Pol; 2007; 58(2):123-9. PubMed ID: 17578828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathology of Neuroendocrine Neoplasms of the Gastrointestinal System.
    Kristína MK; Pavol J; Andrea J; Zuzana Č
    Klin Onkol; 2018; 31(3):167-177. PubMed ID: 30441969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contemporary methods of diagnosis and treatment of neuroendocrine gastrointestinal tumors].
    Kos-Kudła B; Zemczak A
    Endokrynol Pol; 2006; 57(2):174-86. PubMed ID: 16773594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current knowledge on diagnosis and staging of neuroendocrine tumors.
    Oberg K; Castellano D
    Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():3-7. PubMed ID: 21311954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors.
    Massironi S; Conte D; Sciola V; Spampatti MP; Ciafardini C; Valenti L; Rossi RE; Peracchi M
    Am J Gastroenterol; 2010 Sep; 105(9):2072-8. PubMed ID: 20372113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment personalization in gastrointestinal neuroendocrine tumors.
    Borga C; Businello G; Murgioni S; Bergamo F; Martini C; De Carlo E; Trevellin E; Vettor R; Fassan M
    Curr Treat Options Oncol; 2021 Feb; 22(4):29. PubMed ID: 33641005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.